RxDoctor Payments DataLook up a doctor →

Jason Swigert, MD

Internal Medicine · St. George, UTNPI 1558550731

Payments from drug & device makers

$23,122in general payments, 2019–2025

Across 623 payments — averaging $37.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk AS$13K
  • AbbVie$2K
  • Novartis$1K
  • AstraZeneca$794
  • Pfizer$743
  • Novo Nordisk$606
  • plus $6K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk AS1$12,645
AbbVie(2 entities)89$1,560
Novartis58$1,045
AstraZeneca39$794
Pfizer48$743
Novo Nordisk47$606
Amgen(2 entities)33$569
Lilly USA, LLC44$535
Boehringer Ingelheim33$514
Johnson & Johnson30$302
Astellas Pharma US Inc3$298
Boston Scientific9$237
Sanofi-aventis U.S. LLC14$215
Biohaven Pharmaceutical Holding Company Ltd.6$204
Merck13$201
Nestle Healthcare Nutrition Inc.12$201
Abbott14$200
Philips North America LLC10$189
Takeda Pharmaceuticals U.S.A., Inc.13$172
Lundbeck LLC7$167
Teva Pharmaceuticals USA, Inc.7$157
Bayer9$149
Radius Health, Inc.8$140
Aimmune Therapeutics, Inc.7$108
GSK7$105
Neurocrine Biosciences, Inc.4$88
Amarin Pharma, Inc.5$86
Mylan Specialty L.p.4$85
Dexcom, Inc.5$83
Daiichi Sankyo Inc.4$79
Otsuka America Pharmaceutical, Inc.3$56
IBSA Pharma Inc.3$54
Medtronic2$34
Phathom Pharmaceuticals, Inc.2$34
Biohaven Pharmaceuticals, Inc.2$34
Alkermes, Inc.2$32
Idorsia Pharmaceuticals US Inc2$31
Exact Sciences2$30
Tactile Systems Technology Inc2$26
Viatris Specialty LLC1$25
Ironwood Pharmaceuticals, Inc2$24
Nevro Corp.1$23
Vanda Pharmaceuticals Inc.1$22
Lucid Diagnostics Inc.1$21
Xeris Pharmaceuticals, Inc.1$21
Inspire Medical Systems, Inc.1$20
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$20
Strongbridge US Inc.1$18
GE HealthCare1$18
Urovant Sciences Inc1$18
Kyowa Kirin, Inc.1$16
Baxter Healthcare1$15
Esperion Therapeutics, Inc.1$14
Actelion Pharmaceuticals US, Inc.1$13
Eisai Inc.1$13
Sumitomo Pharma America, Inc.2$8
Insightec,inc1$7

How this compares

$23,122 in reported general payments places this provider in the 90th percentile of 496 internal medicine providers in Utah.

See all internal medicine providers in Utah →

Medicare billing

Part B allowed, 2024
$366,955
Medicare patients
810
Services billed
6,272

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in St. George

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →